Literature DB >> 22330684

Gynecological cancer: More evidence supporting human papillomavirus testing.

Philip E Castle.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22330684     DOI： 10.1038/nrclinonc.2012.16

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Authors:  Philip E Castle; Mark H Stoler; Thomas C Wright; Abha Sharma; Teresa L Wright; Catherine M Behrens
Journal:  Lancet Oncol       Date:  2011-08-22       Impact factor: 41.316

2.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

3.  Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.

Authors:  Dorien C Rijkaart; Johannes Berkhof; Lawrence Rozendaal; Folkert J van Kemenade; Nicole W J Bulkmans; Daniëlle A M Heideman; Gemma G Kenter; Jack Cuzick; Peter J F Snijders; Chris J L M Meijer
Journal:  Lancet Oncol       Date:  2011-12-14       Impact factor: 41.316

4.  Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.

Authors:  Guglielmo Ronco; Paolo Giorgi-Rossi; Francesca Carozzi; Massimo Confortini; Paolo Dalla Palma; Annarosa Del Mistro; Bruno Ghiringhello; Salvatore Girlando; Anna Gillio-Tos; Laura De Marco; Carlo Naldoni; Paola Pierotti; Raffaella Rizzolo; Patrizia Schincaglia; Manuel Zorzi; Marco Zappa; Nereo Segnan; Jack Cuzick
Journal:  Lancet Oncol       Date:  2010-01-18       Impact factor: 41.316

5.  Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

Authors:  Pontus Naucler; Walter Ryd; Sven Törnberg; Anders Strand; Göran Wadell; Kristina Elfgren; Thomas Rådberg; Björn Strander; Bo Johansson; Ola Forslund; Bengt-Göran Hansson; Eva Rylander; Joakim Dillner
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

6.  Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

Authors:  Marie-Hélène Mayrand; Eliane Duarte-Franco; Isabel Rodrigues; Stephen D Walter; James Hanley; Alex Ferenczy; Sam Ratnam; François Coutlée; Eduardo L Franco
Journal:  N Engl J Med       Date:  2007-10-18       Impact factor: 91.245

7.  HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

Authors:  Henry C Kitchener; Maribel Almonte; Claire Thomson; Paula Wheeler; Alexandra Sargent; Boyka Stoykova; Clare Gilham; Helene Baysson; Christopher Roberts; Robin Dowie; Mina Desai; Jean Mather; Andrew Bailey; Andrew Turner; Sue Moss; Julian Peto
Journal:  Lancet Oncol       Date:  2009-06-17       Impact factor: 41.316

8.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

9.  Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Authors:  Joakim Dillner; Matejka Rebolj; Philippe Birembaut; Karl-Ulrich Petry; Anne Szarewski; Christian Munk; Silvia de Sanjose; Pontus Naucler; Belen Lloveras; Susanne Kjaer; Jack Cuzick; Marjolein van Ballegooijen; Christine Clavel; Thomas Iftner
Journal:  BMJ       Date:  2008-10-13
  9 in total
  3 in total

Review 1.  Ovarian cancer screening--current status, future directions.

Authors:  Usha Menon; Michelle Griffin; Aleksandra Gentry-Maharaj
Journal:  Gynecol Oncol       Date:  2013-12-03       Impact factor: 5.482

Review 2.  Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes.

Authors:  Laura Feeney; Ian Jg Harley; W Glenn McCluggage; Paul B Mullan; James P Beirne
Journal:  World J Clin Oncol       Date:  2020-11-24

Review 3.  Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis.

Authors:  Hung N Luu; Kristina R Dahlstrom; Patricia Dolan Mullen; Helena M VonVille; Michael E Scheurer
Journal:  Cancer Med       Date:  2013-04-21       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.